Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: a year ago

Possible Interaction: Cannabinoids and Cholecystokinin

Research Papers that Mention the Interaction

This observation suggests that cannabinoids inhibit CCK activation of nodose ganglion neurons.
Physiological reports  •  2018  |  View Paper
Cannabinoids have been shown to modulate the inhibitory effect of cholecystokinin-containing GABAergic interneurons in the hippocampus via type 1 cannabinoid receptors (CB1 receptor).
Neuroscience  •  2005  |  View Paper
The results indicate that cannabinoids may modulate the activity of pyramidal projection neurons as well as a subpopulation of cholecystokinin-containing non-pyramidal neurons in the basolateral amygdala.
Neuroscience  •  2001  |  View Paper
Therefore, we suggest that a putative cross‐talk between cannabinoids and CCK might exist and will be relevant to better understanding of physiology and pharmacology of the cannabinoid system.
The European journal of neuroscience  •  1999  |  View Paper